Overview

Antithrombin III Concentrate After Liver Transplantation

Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This study was designed to demonstrate more effective administration method of AT-III in immediate post-liver transplantation period.
Phase:
N/A
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Antithrombin III
Antithrombins